🇺🇸 FDA
Patent

US 11883432

Chimeric antigen receptor system with adaptable receptor specificity

granted A61KA61K40/11A61K40/31

Quick answer

US patent 11883432 (Chimeric antigen receptor system with adaptable receptor specificity) held by Century Therapeutics, Inc. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Century Therapeutics, Inc.
Grant date
Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K40/11, A61K40/31, A61K40/4204, A61P